nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GRIA3—nerve—multiple sclerosis	0.0336	0.139	CbGeAlD
Lithium—GSK3B—nerve—multiple sclerosis	0.0291	0.121	CbGeAlD
Lithium—GSK3A—retina—multiple sclerosis	0.0105	0.0435	CbGeAlD
Lithium—GRIA3—medulla oblongata—multiple sclerosis	0.0101	0.0417	CbGeAlD
Lithium—GRIA3—midbrain—multiple sclerosis	0.0092	0.0381	CbGeAlD
Lithium—GRIA3—spinal cord—multiple sclerosis	0.00898	0.0372	CbGeAlD
Lithium—IMPA1—nervous system—multiple sclerosis	0.0089	0.0369	CbGeAlD
Lithium—GSK3B—medulla oblongata—multiple sclerosis	0.00872	0.0361	CbGeAlD
Lithium—IMPA1—central nervous system—multiple sclerosis	0.00857	0.0355	CbGeAlD
Lithium—GSK3B—spinal cord—multiple sclerosis	0.00777	0.0322	CbGeAlD
Lithium—GSK3A—medulla oblongata—multiple sclerosis	0.00758	0.0314	CbGeAlD
Lithium—GRIA3—nervous system—multiple sclerosis	0.00756	0.0314	CbGeAlD
Lithium—GRIA3—central nervous system—multiple sclerosis	0.00728	0.0302	CbGeAlD
Lithium—GRIA3—cerebellum—multiple sclerosis	0.00712	0.0295	CbGeAlD
Lithium—GSK3A—midbrain—multiple sclerosis	0.00693	0.0287	CbGeAlD
Lithium—IMPA1—brain—multiple sclerosis	0.0068	0.0282	CbGeAlD
Lithium—GSK3A—spinal cord—multiple sclerosis	0.00676	0.028	CbGeAlD
Lithium—GSK3B—nervous system—multiple sclerosis	0.00655	0.0271	CbGeAlD
Lithium—GSK3B—central nervous system—multiple sclerosis	0.00631	0.0261	CbGeAlD
Lithium—GSK3B—cerebellum—multiple sclerosis	0.00616	0.0255	CbGeAlD
Lithium—GRIA3—brain—multiple sclerosis	0.00578	0.024	CbGeAlD
Lithium—GSK3A—nervous system—multiple sclerosis	0.0057	0.0236	CbGeAlD
Lithium—GSK3A—central nervous system—multiple sclerosis	0.00548	0.0227	CbGeAlD
Lithium—GSK3A—cerebellum—multiple sclerosis	0.00536	0.0222	CbGeAlD
Lithium—IMPA2—brain—multiple sclerosis	0.0051	0.0211	CbGeAlD
Lithium—GSK3B—brain—multiple sclerosis	0.00501	0.0207	CbGeAlD
Lithium—GSK3A—brain—multiple sclerosis	0.00435	0.018	CbGeAlD
Lithium—Hypotension—Azathioprine—multiple sclerosis	0.000649	0.00199	CcSEcCtD
Lithium—Vision blurred—Mitoxantrone—multiple sclerosis	0.000648	0.00199	CcSEcCtD
Lithium—Polyuria—Methotrexate—multiple sclerosis	0.000648	0.00199	CcSEcCtD
Lithium—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000633	0.00194	CcSEcCtD
Lithium—Dry skin—Prednisone—multiple sclerosis	0.000624	0.00191	CcSEcCtD
Lithium—Weight increased—Dexamethasone—multiple sclerosis	0.000615	0.00189	CcSEcCtD
Lithium—Weight increased—Betamethasone—multiple sclerosis	0.000615	0.00189	CcSEcCtD
Lithium—Asthenia—Cladribine—multiple sclerosis	0.000613	0.00188	CcSEcCtD
Lithium—Weight decreased—Dexamethasone—multiple sclerosis	0.000612	0.00188	CcSEcCtD
Lithium—Weight decreased—Betamethasone—multiple sclerosis	0.000612	0.00188	CcSEcCtD
Lithium—Hyperglycaemia—Betamethasone—multiple sclerosis	0.00061	0.00187	CcSEcCtD
Lithium—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.00061	0.00187	CcSEcCtD
Lithium—Bradycardia—Triamcinolone—multiple sclerosis	0.000607	0.00186	CcSEcCtD
Lithium—Bradycardia—Methylprednisolone—multiple sclerosis	0.000606	0.00186	CcSEcCtD
Lithium—Muscular weakness—Prednisone—multiple sclerosis	0.000601	0.00184	CcSEcCtD
Lithium—Convulsion—Mitoxantrone—multiple sclerosis	0.000596	0.00183	CcSEcCtD
Lithium—Hallucination—Methylprednisolone—multiple sclerosis	0.000592	0.00182	CcSEcCtD
Lithium—Arthralgia—Mitoxantrone—multiple sclerosis	0.000586	0.0018	CcSEcCtD
Lithium—Diarrhoea—Cladribine—multiple sclerosis	0.000584	0.00179	CcSEcCtD
Lithium—Lethargy—Methotrexate—multiple sclerosis	0.000581	0.00178	CcSEcCtD
Lithium—Arrhythmia—Prednisolone—multiple sclerosis	0.000579	0.00178	CcSEcCtD
Lithium—Discomfort—Mitoxantrone—multiple sclerosis	0.000579	0.00178	CcSEcCtD
Lithium—Feeling abnormal—Azathioprine—multiple sclerosis	0.000572	0.00176	CcSEcCtD
Lithium—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000568	0.00174	CcSEcCtD
Lithium—Confusional state—Mitoxantrone—multiple sclerosis	0.000566	0.00174	CcSEcCtD
Lithium—Dizziness—Cladribine—multiple sclerosis	0.000565	0.00173	CcSEcCtD
Lithium—Oedema—Mitoxantrone—multiple sclerosis	0.000562	0.00172	CcSEcCtD
Lithium—Shock—Mitoxantrone—multiple sclerosis	0.000552	0.00169	CcSEcCtD
Lithium—Bradycardia—Betamethasone—multiple sclerosis	0.000551	0.00169	CcSEcCtD
Lithium—Bradycardia—Dexamethasone—multiple sclerosis	0.000551	0.00169	CcSEcCtD
Lithium—Abdominal pain—Azathioprine—multiple sclerosis	0.000549	0.00168	CcSEcCtD
Lithium—Body temperature increased—Azathioprine—multiple sclerosis	0.000549	0.00168	CcSEcCtD
Lithium—Vomiting—Cladribine—multiple sclerosis	0.000543	0.00167	CcSEcCtD
Lithium—Erectile dysfunction—Prednisone—multiple sclerosis	0.000542	0.00166	CcSEcCtD
Lithium—Rash—Cladribine—multiple sclerosis	0.000539	0.00165	CcSEcCtD
Lithium—Hallucination—Betamethasone—multiple sclerosis	0.000538	0.00165	CcSEcCtD
Lithium—Hallucination—Dexamethasone—multiple sclerosis	0.000538	0.00165	CcSEcCtD
Lithium—Dermatitis—Cladribine—multiple sclerosis	0.000538	0.00165	CcSEcCtD
Lithium—Weight increased—Prednisone—multiple sclerosis	0.000536	0.00164	CcSEcCtD
Lithium—Anorexia—Mitoxantrone—multiple sclerosis	0.000535	0.00164	CcSEcCtD
Lithium—Ataxia—Methotrexate—multiple sclerosis	0.000535	0.00164	CcSEcCtD
Lithium—Headache—Cladribine—multiple sclerosis	0.000535	0.00164	CcSEcCtD
Lithium—Arrhythmia—Triamcinolone—multiple sclerosis	0.000533	0.00163	CcSEcCtD
Lithium—Weight decreased—Prednisone—multiple sclerosis	0.000533	0.00163	CcSEcCtD
Lithium—Vision blurred—Prednisolone—multiple sclerosis	0.000532	0.00163	CcSEcCtD
Lithium—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000531	0.00163	CcSEcCtD
Lithium—Hyperglycaemia—Prednisone—multiple sclerosis	0.000531	0.00163	CcSEcCtD
Lithium—Hypotension—Mitoxantrone—multiple sclerosis	0.000525	0.00161	CcSEcCtD
Lithium—Angioedema—Prednisolone—multiple sclerosis	0.000516	0.00158	CcSEcCtD
Lithium—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000512	0.00157	CcSEcCtD
Lithium—Dysgeusia—Triamcinolone—multiple sclerosis	0.000508	0.00156	CcSEcCtD
Lithium—Nausea—Cladribine—multiple sclerosis	0.000507	0.00156	CcSEcCtD
Lithium—Vertigo—Prednisolone—multiple sclerosis	0.000507	0.00156	CcSEcCtD
Lithium—Syncope—Prednisolone—multiple sclerosis	0.000506	0.00155	CcSEcCtD
Lithium—Somnolence—Mitoxantrone—multiple sclerosis	0.000499	0.00153	CcSEcCtD
Lithium—Loss of consciousness—Prednisolone—multiple sclerosis	0.000496	0.00152	CcSEcCtD
Lithium—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000494	0.00152	CcSEcCtD
Lithium—Convulsion—Prednisolone—multiple sclerosis	0.000489	0.0015	CcSEcCtD
Lithium—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000488	0.0015	CcSEcCtD
Lithium—Fatigue—Mitoxantrone—multiple sclerosis	0.000484	0.00148	CcSEcCtD
Lithium—Arrhythmia—Dexamethasone—multiple sclerosis	0.000483	0.00148	CcSEcCtD
Lithium—Arrhythmia—Betamethasone—multiple sclerosis	0.000483	0.00148	CcSEcCtD
Lithium—Bradycardia—Prednisone—multiple sclerosis	0.00048	0.00147	CcSEcCtD
Lithium—Alopecia—Dexamethasone—multiple sclerosis	0.000478	0.00147	CcSEcCtD
Lithium—Alopecia—Betamethasone—multiple sclerosis	0.000478	0.00147	CcSEcCtD
Lithium—Diarrhoea—Azathioprine—multiple sclerosis	0.000475	0.00146	CcSEcCtD
Lithium—Discomfort—Prednisolone—multiple sclerosis	0.000475	0.00146	CcSEcCtD
Lithium—Angioedema—Triamcinolone—multiple sclerosis	0.000474	0.00145	CcSEcCtD
Lithium—Angioedema—Methylprednisolone—multiple sclerosis	0.000473	0.00145	CcSEcCtD
Lithium—Hallucination—Prednisone—multiple sclerosis	0.000469	0.00144	CcSEcCtD
Lithium—Vertigo—Triamcinolone—multiple sclerosis	0.000466	0.00143	CcSEcCtD
Lithium—Syncope—Triamcinolone—multiple sclerosis	0.000465	0.00143	CcSEcCtD
Lithium—Vertigo—Methylprednisolone—multiple sclerosis	0.000465	0.00143	CcSEcCtD
Lithium—Syncope—Methylprednisolone—multiple sclerosis	0.000464	0.00142	CcSEcCtD
Lithium—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000463	0.00142	CcSEcCtD
Lithium—Oedema—Prednisolone—multiple sclerosis	0.000461	0.00141	CcSEcCtD
Lithium—Dizziness—Azathioprine—multiple sclerosis	0.000459	0.00141	CcSEcCtD
Lithium—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000459	0.00141	CcSEcCtD
Lithium—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000456	0.0014	CcSEcCtD
Lithium—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000455	0.0014	CcSEcCtD
Lithium—Shock—Prednisolone—multiple sclerosis	0.000453	0.00139	CcSEcCtD
Lithium—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000453	0.00139	CcSEcCtD
Lithium—Convulsion—Triamcinolone—multiple sclerosis	0.00045	0.00138	CcSEcCtD
Lithium—Convulsion—Methylprednisolone—multiple sclerosis	0.000449	0.00138	CcSEcCtD
Lithium—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000444	0.00136	CcSEcCtD
Lithium—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000444	0.00136	CcSEcCtD
Lithium—Vomiting—Azathioprine—multiple sclerosis	0.000442	0.00135	CcSEcCtD
Lithium—Arthralgia—Methylprednisolone—multiple sclerosis	0.000441	0.00135	CcSEcCtD
Lithium—Drowsiness—Methotrexate—multiple sclerosis	0.000439	0.00135	CcSEcCtD
Lithium—Rash—Azathioprine—multiple sclerosis	0.000438	0.00134	CcSEcCtD
Lithium—Dermatitis—Azathioprine—multiple sclerosis	0.000438	0.00134	CcSEcCtD
Lithium—Discomfort—Triamcinolone—multiple sclerosis	0.000437	0.00134	CcSEcCtD
Lithium—Discomfort—Methylprednisolone—multiple sclerosis	0.000436	0.00134	CcSEcCtD
Lithium—Headache—Azathioprine—multiple sclerosis	0.000435	0.00133	CcSEcCtD
Lithium—Dry mouth—Triamcinolone—multiple sclerosis	0.000432	0.00133	CcSEcCtD
Lithium—Angioedema—Dexamethasone—multiple sclerosis	0.00043	0.00132	CcSEcCtD
Lithium—Angioedema—Betamethasone—multiple sclerosis	0.00043	0.00132	CcSEcCtD
Lithium—Confusional state—Methylprednisolone—multiple sclerosis	0.000426	0.00131	CcSEcCtD
Lithium—Oedema—Triamcinolone—multiple sclerosis	0.000424	0.0013	CcSEcCtD
Lithium—Vertigo—Dexamethasone—multiple sclerosis	0.000423	0.0013	CcSEcCtD
Lithium—Vertigo—Betamethasone—multiple sclerosis	0.000423	0.0013	CcSEcCtD
Lithium—Syncope—Dexamethasone—multiple sclerosis	0.000422	0.0013	CcSEcCtD
Lithium—Syncope—Betamethasone—multiple sclerosis	0.000422	0.0013	CcSEcCtD
Lithium—Arrhythmia—Prednisone—multiple sclerosis	0.000421	0.00129	CcSEcCtD
Lithium—Shock—Triamcinolone—multiple sclerosis	0.000417	0.00128	CcSEcCtD
Lithium—Alopecia—Prednisone—multiple sclerosis	0.000416	0.00128	CcSEcCtD
Lithium—Shock—Methylprednisolone—multiple sclerosis	0.000416	0.00128	CcSEcCtD
Lithium—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000414	0.00127	CcSEcCtD
Lithium—Loss of consciousness—Betamethasone—multiple sclerosis	0.000414	0.00127	CcSEcCtD
Lithium—Nausea—Azathioprine—multiple sclerosis	0.000413	0.00127	CcSEcCtD
Lithium—Convulsion—Dexamethasone—multiple sclerosis	0.000408	0.00125	CcSEcCtD
Lithium—Convulsion—Betamethasone—multiple sclerosis	0.000408	0.00125	CcSEcCtD
Lithium—Asthenia—Mitoxantrone—multiple sclerosis	0.000403	0.00124	CcSEcCtD
Lithium—Discomfort—Dexamethasone—multiple sclerosis	0.000396	0.00122	CcSEcCtD
Lithium—Discomfort—Betamethasone—multiple sclerosis	0.000396	0.00122	CcSEcCtD
Lithium—Hypotension—Methylprednisolone—multiple sclerosis	0.000395	0.00121	CcSEcCtD
Lithium—Vision blurred—Prednisone—multiple sclerosis	0.000387	0.00119	CcSEcCtD
Lithium—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000386	0.00118	CcSEcCtD
Lithium—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000385	0.00118	CcSEcCtD
Lithium—Oedema—Betamethasone—multiple sclerosis	0.000384	0.00118	CcSEcCtD
Lithium—Oedema—Dexamethasone—multiple sclerosis	0.000384	0.00118	CcSEcCtD
Lithium—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000384	0.00118	CcSEcCtD
Lithium—Feeling abnormal—Prednisolone—multiple sclerosis	0.00038	0.00116	CcSEcCtD
Lithium—Shock—Dexamethasone—multiple sclerosis	0.000378	0.00116	CcSEcCtD
Lithium—Shock—Betamethasone—multiple sclerosis	0.000378	0.00116	CcSEcCtD
Lithium—Agitation—Prednisone—multiple sclerosis	0.000377	0.00116	CcSEcCtD
Lithium—Angioedema—Prednisone—multiple sclerosis	0.000375	0.00115	CcSEcCtD
Lithium—Dyspepsia—Triamcinolone—multiple sclerosis	0.000373	0.00114	CcSEcCtD
Lithium—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000372	0.00114	CcSEcCtD
Lithium—Vertigo—Prednisone—multiple sclerosis	0.000369	0.00113	CcSEcCtD
Lithium—Syncope—Prednisone—multiple sclerosis	0.000368	0.00113	CcSEcCtD
Lithium—Tinnitus—Methotrexate—multiple sclerosis	0.000367	0.00113	CcSEcCtD
Lithium—Anorexia—Dexamethasone—multiple sclerosis	0.000366	0.00112	CcSEcCtD
Lithium—Anorexia—Betamethasone—multiple sclerosis	0.000366	0.00112	CcSEcCtD
Lithium—Fatigue—Triamcinolone—multiple sclerosis	0.000365	0.00112	CcSEcCtD
Lithium—Fatigue—Methylprednisolone—multiple sclerosis	0.000364	0.00112	CcSEcCtD
Lithium—Loss of consciousness—Prednisone—multiple sclerosis	0.000361	0.00111	CcSEcCtD
Lithium—Hypotension—Betamethasone—multiple sclerosis	0.000359	0.0011	CcSEcCtD
Lithium—Hypotension—Dexamethasone—multiple sclerosis	0.000359	0.0011	CcSEcCtD
Lithium—Vomiting—Mitoxantrone—multiple sclerosis	0.000357	0.0011	CcSEcCtD
Lithium—Convulsion—Prednisone—multiple sclerosis	0.000355	0.00109	CcSEcCtD
Lithium—Rash—Mitoxantrone—multiple sclerosis	0.000354	0.00109	CcSEcCtD
Lithium—Dermatitis—Mitoxantrone—multiple sclerosis	0.000354	0.00108	CcSEcCtD
Lithium—Headache—Mitoxantrone—multiple sclerosis	0.000352	0.00108	CcSEcCtD
Lithium—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00035	0.00107	CcSEcCtD
Lithium—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00035	0.00107	CcSEcCtD
Lithium—Arthralgia—Prednisone—multiple sclerosis	0.000349	0.00107	CcSEcCtD
Lithium—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000349	0.00107	CcSEcCtD
Lithium—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000348	0.00107	CcSEcCtD
Lithium—Alopecia—Methotrexate—multiple sclerosis	0.000348	0.00107	CcSEcCtD
Lithium—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000346	0.00106	CcSEcCtD
Lithium—Discomfort—Prednisone—multiple sclerosis	0.000345	0.00106	CcSEcCtD
Lithium—Dyspepsia—Dexamethasone—multiple sclerosis	0.000338	0.00104	CcSEcCtD
Lithium—Dyspepsia—Betamethasone—multiple sclerosis	0.000338	0.00104	CcSEcCtD
Lithium—Dysgeusia—Methotrexate—multiple sclerosis	0.000336	0.00103	CcSEcCtD
Lithium—Body temperature increased—Triamcinolone—multiple sclerosis	0.000335	0.00103	CcSEcCtD
Lithium—Oedema—Prednisone—multiple sclerosis	0.000335	0.00103	CcSEcCtD
Lithium—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000334	0.00102	CcSEcCtD
Lithium—Decreased appetite—Betamethasone—multiple sclerosis	0.000334	0.00102	CcSEcCtD
Lithium—Decreased appetite—Dexamethasone—multiple sclerosis	0.000334	0.00102	CcSEcCtD
Lithium—Nausea—Mitoxantrone—multiple sclerosis	0.000334	0.00102	CcSEcCtD
Lithium—Fatigue—Dexamethasone—multiple sclerosis	0.000331	0.00102	CcSEcCtD
Lithium—Fatigue—Betamethasone—multiple sclerosis	0.000331	0.00102	CcSEcCtD
Lithium—Shock—Prednisone—multiple sclerosis	0.000329	0.00101	CcSEcCtD
Lithium—Vision blurred—Methotrexate—multiple sclerosis	0.000323	0.000991	CcSEcCtD
Lithium—Anorexia—Prednisone—multiple sclerosis	0.000319	0.000979	CcSEcCtD
Lithium—Feeling abnormal—Betamethasone—multiple sclerosis	0.000317	0.000972	CcSEcCtD
Lithium—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000317	0.000972	CcSEcCtD
Lithium—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000314	0.000964	CcSEcCtD
Lithium—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000314	0.000964	CcSEcCtD
Lithium—Vertigo—Methotrexate—multiple sclerosis	0.000308	0.000945	CcSEcCtD
Lithium—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000305	0.000935	CcSEcCtD
Lithium—Dizziness—Prednisolone—multiple sclerosis	0.000305	0.000934	CcSEcCtD
Lithium—Asthenia—Triamcinolone—multiple sclerosis	0.000304	0.000932	CcSEcCtD
Lithium—Body temperature increased—Betamethasone—multiple sclerosis	0.000304	0.000932	CcSEcCtD
Lithium—Abdominal pain—Dexamethasone—multiple sclerosis	0.000304	0.000932	CcSEcCtD
Lithium—Abdominal pain—Betamethasone—multiple sclerosis	0.000304	0.000932	CcSEcCtD
Lithium—Body temperature increased—Dexamethasone—multiple sclerosis	0.000304	0.000932	CcSEcCtD
Lithium—Asthenia—Methylprednisolone—multiple sclerosis	0.000303	0.00093	CcSEcCtD
Lithium—Convulsion—Methotrexate—multiple sclerosis	0.000297	0.000911	CcSEcCtD
Lithium—Dyspepsia—Prednisone—multiple sclerosis	0.000295	0.000904	CcSEcCtD
Lithium—Arthralgia—Methotrexate—multiple sclerosis	0.000292	0.000895	CcSEcCtD
Lithium—Decreased appetite—Prednisone—multiple sclerosis	0.000291	0.000893	CcSEcCtD
Lithium—Rash—Prednisolone—multiple sclerosis	0.00029	0.000891	CcSEcCtD
Lithium—Dermatitis—Prednisolone—multiple sclerosis	0.00029	0.00089	CcSEcCtD
Lithium—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000289	0.000887	CcSEcCtD
Lithium—Fatigue—Prednisone—multiple sclerosis	0.000289	0.000885	CcSEcCtD
Lithium—Headache—Prednisolone—multiple sclerosis	0.000289	0.000885	CcSEcCtD
Lithium—Discomfort—Methotrexate—multiple sclerosis	0.000288	0.000884	CcSEcCtD
Lithium—Confusional state—Methotrexate—multiple sclerosis	0.000282	0.000865	CcSEcCtD
Lithium—Dizziness—Triamcinolone—multiple sclerosis	0.00028	0.000859	CcSEcCtD
Lithium—Dizziness—Methylprednisolone—multiple sclerosis	0.00028	0.000857	CcSEcCtD
Lithium—Feeling abnormal—Prednisone—multiple sclerosis	0.000276	0.000846	CcSEcCtD
Lithium—Asthenia—Dexamethasone—multiple sclerosis	0.000276	0.000846	CcSEcCtD
Lithium—Asthenia—Betamethasone—multiple sclerosis	0.000276	0.000846	CcSEcCtD
Lithium—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000274	0.00084	CcSEcCtD
Lithium—Nausea—Prednisolone—multiple sclerosis	0.000274	0.000839	CcSEcCtD
Lithium—Vomiting—Triamcinolone—multiple sclerosis	0.000269	0.000826	CcSEcCtD
Lithium—Vomiting—Methylprednisolone—multiple sclerosis	0.000269	0.000824	CcSEcCtD
Lithium—Rash—Triamcinolone—multiple sclerosis	0.000267	0.000819	CcSEcCtD
Lithium—Dermatitis—Triamcinolone—multiple sclerosis	0.000267	0.000819	CcSEcCtD
Lithium—Anorexia—Methotrexate—multiple sclerosis	0.000267	0.000818	CcSEcCtD
Lithium—Rash—Methylprednisolone—multiple sclerosis	0.000267	0.000817	CcSEcCtD
Lithium—Dermatitis—Methylprednisolone—multiple sclerosis	0.000266	0.000817	CcSEcCtD
Lithium—Headache—Triamcinolone—multiple sclerosis	0.000265	0.000814	CcSEcCtD
Lithium—Headache—Methylprednisolone—multiple sclerosis	0.000265	0.000812	CcSEcCtD
Lithium—Body temperature increased—Prednisone—multiple sclerosis	0.000265	0.000812	CcSEcCtD
Lithium—Abdominal pain—Prednisone—multiple sclerosis	0.000265	0.000812	CcSEcCtD
Lithium—Diarrhoea—Dexamethasone—multiple sclerosis	0.000263	0.000807	CcSEcCtD
Lithium—Diarrhoea—Betamethasone—multiple sclerosis	0.000263	0.000807	CcSEcCtD
Lithium—Hypotension—Methotrexate—multiple sclerosis	0.000261	0.000802	CcSEcCtD
Lithium—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000255	0.000782	CcSEcCtD
Lithium—Dizziness—Dexamethasone—multiple sclerosis	0.000254	0.00078	CcSEcCtD
Lithium—Dizziness—Betamethasone—multiple sclerosis	0.000254	0.00078	CcSEcCtD
Lithium—Nausea—Triamcinolone—multiple sclerosis	0.000252	0.000772	CcSEcCtD
Lithium—Nausea—Methylprednisolone—multiple sclerosis	0.000251	0.00077	CcSEcCtD
Lithium—Somnolence—Methotrexate—multiple sclerosis	0.000249	0.000763	CcSEcCtD
Lithium—Dyspepsia—Methotrexate—multiple sclerosis	0.000246	0.000755	CcSEcCtD
Lithium—Vomiting—Dexamethasone—multiple sclerosis	0.000244	0.00075	CcSEcCtD
Lithium—Vomiting—Betamethasone—multiple sclerosis	0.000244	0.00075	CcSEcCtD
Lithium—Decreased appetite—Methotrexate—multiple sclerosis	0.000243	0.000746	CcSEcCtD
Lithium—Rash—Betamethasone—multiple sclerosis	0.000242	0.000743	CcSEcCtD
Lithium—Rash—Dexamethasone—multiple sclerosis	0.000242	0.000743	CcSEcCtD
Lithium—Dermatitis—Dexamethasone—multiple sclerosis	0.000242	0.000743	CcSEcCtD
Lithium—Dermatitis—Betamethasone—multiple sclerosis	0.000242	0.000743	CcSEcCtD
Lithium—Fatigue—Methotrexate—multiple sclerosis	0.000241	0.00074	CcSEcCtD
Lithium—Headache—Betamethasone—multiple sclerosis	0.000241	0.000739	CcSEcCtD
Lithium—Headache—Dexamethasone—multiple sclerosis	0.000241	0.000739	CcSEcCtD
Lithium—Asthenia—Prednisone—multiple sclerosis	0.00024	0.000737	CcSEcCtD
Lithium—Feeling abnormal—Methotrexate—multiple sclerosis	0.000231	0.000707	CcSEcCtD
Lithium—IMPA1—Metabolism—POMC—multiple sclerosis	0.00023	0.000532	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—IL6—multiple sclerosis	0.00023	0.000531	CbGpPWpGaD
Lithium—Diarrhoea—Prednisone—multiple sclerosis	0.000229	0.000703	CcSEcCtD
Lithium—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000229	0.000702	CcSEcCtD
Lithium—GSK3A—DAP12 signaling—IL6—multiple sclerosis	0.000229	0.000528	CbGpPWpGaD
Lithium—Nausea—Dexamethasone—multiple sclerosis	0.000228	0.0007	CcSEcCtD
Lithium—Nausea—Betamethasone—multiple sclerosis	0.000228	0.0007	CcSEcCtD
Lithium—GSK3B—Signaling by FGFR in disease—STAT3—multiple sclerosis	0.000228	0.000526	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD28—multiple sclerosis	0.000227	0.000524	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—MAPK1—multiple sclerosis	0.000224	0.000518	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—S1PR1—multiple sclerosis	0.000224	0.000517	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL13—multiple sclerosis	0.000223	0.000516	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCR1—multiple sclerosis	0.000223	0.000516	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—MAPK1—multiple sclerosis	0.000223	0.000516	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—STAT3—multiple sclerosis	0.000223	0.000514	CbGpPWpGaD
Lithium—GSK3A—Immune System—CCR2—multiple sclerosis	0.000222	0.000514	CbGpPWpGaD
Lithium—GSK3A—Immune System—PTPRC—multiple sclerosis	0.000222	0.000514	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—MAPK1—multiple sclerosis	0.000222	0.000513	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—TYK2—multiple sclerosis	0.000221	0.000512	CbGpPWpGaD
Lithium—Dizziness—Prednisone—multiple sclerosis	0.000221	0.000679	CcSEcCtD
Lithium—Abdominal pain—Methotrexate—multiple sclerosis	0.000221	0.000678	CcSEcCtD
Lithium—Body temperature increased—Methotrexate—multiple sclerosis	0.000221	0.000678	CcSEcCtD
Lithium—GSK3B—Signaling by ERBB2—MAPK1—multiple sclerosis	0.000221	0.000511	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—MAPK1—multiple sclerosis	0.00022	0.000508	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—TLR4—multiple sclerosis	0.000219	0.000507	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—VCAM1—multiple sclerosis	0.000219	0.000507	CbGpPWpGaD
Lithium—GSK3B—Immune System—NOD1—multiple sclerosis	0.000219	0.000506	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-DQA1—multiple sclerosis	0.000219	0.000505	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GPC5—multiple sclerosis	0.000218	0.000503	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—IL6—multiple sclerosis	0.000215	0.000497	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—IL6—multiple sclerosis	0.000215	0.000497	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—IL6—multiple sclerosis	0.000215	0.000497	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-DPB1—multiple sclerosis	0.000215	0.000497	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—IL6—multiple sclerosis	0.000213	0.000493	CbGpPWpGaD
Lithium—Vomiting—Prednisone—multiple sclerosis	0.000213	0.000653	CcSEcCtD
Lithium—GSK3B—Immune System—MALT1—multiple sclerosis	0.000211	0.000488	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—IL6—multiple sclerosis	0.000211	0.000488	CbGpPWpGaD
Lithium—Rash—Prednisone—multiple sclerosis	0.000211	0.000647	CcSEcCtD
Lithium—Dermatitis—Prednisone—multiple sclerosis	0.000211	0.000647	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—HLA-DRB1—multiple sclerosis	0.00021	0.000486	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—IL6—multiple sclerosis	0.00021	0.000486	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—STAT3—multiple sclerosis	0.00021	0.000485	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ALB—multiple sclerosis	0.00021	0.000485	CbGpPWpGaD
Lithium—Headache—Prednisone—multiple sclerosis	0.00021	0.000643	CcSEcCtD
Lithium—GSK3A—Disease—CD28—multiple sclerosis	0.000209	0.000483	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRF5—multiple sclerosis	0.000208	0.000481	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—MAPK1—multiple sclerosis	0.000207	0.000478	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—MAPK1—multiple sclerosis	0.000207	0.000478	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—MAPK1—multiple sclerosis	0.000207	0.000478	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD40—multiple sclerosis	0.000207	0.000478	CbGpPWpGaD
Lithium—GSK3A—Immune System—ITGA4—multiple sclerosis	0.000207	0.000478	CbGpPWpGaD
Lithium—GSK3A—Immune System—IFNB1—multiple sclerosis	0.000205	0.000474	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD86—multiple sclerosis	0.000205	0.000474	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—MAPK1—multiple sclerosis	0.000205	0.000474	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-DQB1—multiple sclerosis	0.000204	0.000473	CbGpPWpGaD
Lithium—GSK3A—Immune System—CTLA4—multiple sclerosis	0.000204	0.000471	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—MAPK1—multiple sclerosis	0.000203	0.00047	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CD80—multiple sclerosis	0.000202	0.000468	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—MAPK1—multiple sclerosis	0.000202	0.000468	CbGpPWpGaD
Lithium—GSK3B—Disease—RPL5—multiple sclerosis	0.000202	0.000467	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—ICAM1—multiple sclerosis	0.000202	0.000467	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—STAT3—multiple sclerosis	0.000202	0.000466	CbGpPWpGaD
Lithium—Asthenia—Methotrexate—multiple sclerosis	0.000201	0.000616	CcSEcCtD
Lithium—GSK3B—Axon guidance—TYK2—multiple sclerosis	0.0002	0.000463	CbGpPWpGaD
Lithium—Nausea—Prednisone—multiple sclerosis	0.000199	0.00061	CcSEcCtD
Lithium—GSK3B—Immune System—HLA-G—multiple sclerosis	0.000199	0.000459	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRF8—multiple sclerosis	0.000199	0.000459	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFIH1—multiple sclerosis	0.000199	0.000459	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD86—multiple sclerosis	0.000197	0.000455	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—MAPK1—multiple sclerosis	0.000195	0.000452	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD80—multiple sclerosis	0.000194	0.000449	CbGpPWpGaD
Lithium—GSK3B—Disease—SLC11A1—multiple sclerosis	0.000194	0.000447	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD40LG—multiple sclerosis	0.000193	0.000446	CbGpPWpGaD
Lithium—Diarrhoea—Methotrexate—multiple sclerosis	0.000191	0.000587	CcSEcCtD
Lithium—GSK3B—Innate Immune System—HLA-B—multiple sclerosis	0.000191	0.000442	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD8A—multiple sclerosis	0.000191	0.000441	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—MAPK1—multiple sclerosis	0.000191	0.000441	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—IL6—multiple sclerosis	0.000191	0.000441	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	0.000191	0.00044	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RGS1—multiple sclerosis	0.00019	0.00044	CbGpPWpGaD
Lithium—GSK3B—Immune System—TNFAIP3—multiple sclerosis	0.000186	0.00043	CbGpPWpGaD
Lithium—Dizziness—Methotrexate—multiple sclerosis	0.000185	0.000567	CcSEcCtD
Lithium—GSK3B—Adaptive Immune System—HLA-B—multiple sclerosis	0.000184	0.000424	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	0.000183	0.000423	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—IL6—multiple sclerosis	0.000182	0.000422	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GPR65—multiple sclerosis	0.00018	0.000417	CbGpPWpGaD
Lithium—GSK3A—Immune System—VCAM1—multiple sclerosis	0.00018	0.000416	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—IL6—multiple sclerosis	0.00018	0.000415	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-DQA1—multiple sclerosis	0.000179	0.000415	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—MYC—multiple sclerosis	0.000179	0.000414	CbGpPWpGaD
Lithium—Vomiting—Methotrexate—multiple sclerosis	0.000178	0.000546	CcSEcCtD
Lithium—Rash—Methotrexate—multiple sclerosis	0.000176	0.000541	CcSEcCtD
Lithium—Dermatitis—Methotrexate—multiple sclerosis	0.000176	0.000541	CcSEcCtD
Lithium—Headache—Methotrexate—multiple sclerosis	0.000175	0.000538	CcSEcCtD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—MYC—multiple sclerosis	0.000173	0.0004	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—IL6—multiple sclerosis	0.000171	0.000396	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—TYK2—multiple sclerosis	0.000171	0.000395	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—IL6—multiple sclerosis	0.000171	0.000394	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-A—multiple sclerosis	0.00017	0.000393	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—IL6—multiple sclerosis	0.00017	0.000392	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—IL6—multiple sclerosis	0.000169	0.00039	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—POMC—multiple sclerosis	0.000168	0.000388	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-DQB1—multiple sclerosis	0.000168	0.000388	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD28—multiple sclerosis	0.000167	0.000387	CbGpPWpGaD
Lithium—Nausea—Methotrexate—multiple sclerosis	0.000166	0.00051	CcSEcCtD
Lithium—GSK3B—Cellular responses to stress—STAT3—multiple sclerosis	0.000165	0.000382	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL13—multiple sclerosis	0.000165	0.000381	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCR1—multiple sclerosis	0.000165	0.000381	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—CCL2—multiple sclerosis	0.000164	0.00038	CbGpPWpGaD
Lithium—GSK3B—Immune System—CCR2—multiple sclerosis	0.000164	0.00038	CbGpPWpGaD
Lithium—GSK3B—Immune System—PTPRC—multiple sclerosis	0.000164	0.00038	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TLR4—multiple sclerosis	0.000162	0.000375	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD86—multiple sclerosis	0.000162	0.000374	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—MYC—multiple sclerosis	0.000161	0.000372	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL3—multiple sclerosis	0.000159	0.000368	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6—multiple sclerosis	0.000159	0.000367	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6—multiple sclerosis	0.000159	0.000367	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—IL6—multiple sclerosis	0.000159	0.000367	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-DPB1—multiple sclerosis	0.000159	0.000367	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD40LG—multiple sclerosis	0.000158	0.000366	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—MMP9—multiple sclerosis	0.000158	0.000365	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—IL6—multiple sclerosis	0.000158	0.000364	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD8A—multiple sclerosis	0.000157	0.000362	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6—multiple sclerosis	0.000156	0.000361	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-DRB1—multiple sclerosis	0.000155	0.000359	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—IL6—multiple sclerosis	0.000155	0.000359	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—STAT3—multiple sclerosis	0.000155	0.000358	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CD4—multiple sclerosis	0.000155	0.000357	CbGpPWpGaD
Lithium—GSK3B—Disease—CD28—multiple sclerosis	0.000155	0.000357	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PTGER4—multiple sclerosis	0.000153	0.000354	CbGpPWpGaD
Lithium—GSK3B—Immune System—ITGA4—multiple sclerosis	0.000153	0.000353	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD40—multiple sclerosis	0.000153	0.000353	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNB1—multiple sclerosis	0.000152	0.000351	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-B—multiple sclerosis	0.000151	0.000348	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PGR—multiple sclerosis	0.000151	0.000348	CbGpPWpGaD
Lithium—GSK3B—Immune System—CTLA4—multiple sclerosis	0.000151	0.000348	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—MAPK1—multiple sclerosis	0.00015	0.000347	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD80—multiple sclerosis	0.00015	0.000346	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—ICAM1—multiple sclerosis	0.000149	0.000345	CbGpPWpGaD
Lithium—GSK3A—Disease—CD86—multiple sclerosis	0.000149	0.000345	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD4—multiple sclerosis	0.000148	0.000343	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCR3—multiple sclerosis	0.000148	0.000342	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IL6—multiple sclerosis	0.000147	0.000339	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CD28—multiple sclerosis	0.000146	0.000338	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCR2—multiple sclerosis	0.000144	0.000332	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD80—multiple sclerosis	0.000144	0.000332	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—IL6—multiple sclerosis	0.000144	0.000332	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TYK2—multiple sclerosis	0.000143	0.00033	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL2RA—multiple sclerosis	0.000141	0.000326	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—MAPK1—multiple sclerosis	0.000141	0.000326	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	0.000141	0.000325	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-A—multiple sclerosis	0.00014	0.000323	CbGpPWpGaD
Lithium—GSK3B—Immune System—VCAM1—multiple sclerosis	0.000133	0.000307	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CNR1—multiple sclerosis	0.000133	0.000307	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—MYC—multiple sclerosis	0.000133	0.000307	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-DQA1—multiple sclerosis	0.000133	0.000306	CbGpPWpGaD
Lithium—GSK3A—Disease—CCR5—multiple sclerosis	0.000132	0.000306	CbGpPWpGaD
Lithium—GSK3A—Disease—HLA-A—multiple sclerosis	0.000129	0.000298	CbGpPWpGaD
Lithium—GSK3A—Immune System—TLR4—multiple sclerosis	0.000128	0.000295	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-DRB1—multiple sclerosis	0.000128	0.000295	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—MAPK1—multiple sclerosis	0.000128	0.000295	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TYK2—multiple sclerosis	0.000126	0.000292	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-DQB1—multiple sclerosis	0.000124	0.000287	CbGpPWpGaD
Lithium—GSK3A—Immune System—ICAM1—multiple sclerosis	0.000122	0.000283	CbGpPWpGaD
Lithium—GSK3A—Disease—APOE—multiple sclerosis	0.00012	0.000278	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL10—multiple sclerosis	0.000119	0.000276	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD86—multiple sclerosis	0.000119	0.000276	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD80—multiple sclerosis	0.000118	0.000272	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL3—multiple sclerosis	0.000118	0.000272	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD40LG—multiple sclerosis	0.000117	0.000271	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD8A—multiple sclerosis	0.000116	0.000268	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—multiple sclerosis	0.000115	0.000267	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD4—multiple sclerosis	0.000114	0.000264	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTGER4—multiple sclerosis	0.000113	0.000261	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MMP9—multiple sclerosis	0.000113	0.00026	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-B—multiple sclerosis	0.000111	0.000257	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PGR—multiple sclerosis	0.000111	0.000257	CbGpPWpGaD
Lithium—GSK3B—Disease—CD86—multiple sclerosis	0.00011	0.000255	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD4—multiple sclerosis	0.00011	0.000253	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCR3—multiple sclerosis	0.000109	0.000252	CbGpPWpGaD
Lithium—GSK3A—Disease—CD80—multiple sclerosis	0.000109	0.000252	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MAPK1—multiple sclerosis	0.000109	0.000251	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—multiple sclerosis	0.000108	0.00025	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CD28—multiple sclerosis	0.000108	0.00025	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCR2—multiple sclerosis	0.000106	0.000246	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CD86—multiple sclerosis	0.000104	0.000241	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL2RA—multiple sclerosis	0.000104	0.000241	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-A—multiple sclerosis	0.000103	0.000239	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL5—multiple sclerosis	0.000103	0.000238	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—STAT3—multiple sclerosis	0.0001	0.000231	CbGpPWpGaD
Lithium—GSK3A—Immune System—TYK2—multiple sclerosis	9.95e-05	0.00023	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CNR1—multiple sclerosis	9.81e-05	0.000227	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—multiple sclerosis	9.8e-05	0.000226	CbGpPWpGaD
Lithium—GSK3B—Disease—CCR5—multiple sclerosis	9.78e-05	0.000226	CbGpPWpGaD
Lithium—GSK3B—Disease—HLA-A—multiple sclerosis	9.53e-05	0.00022	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SPP1—multiple sclerosis	9.53e-05	0.00022	CbGpPWpGaD
Lithium—GSK3B—Immune System—TLR4—multiple sclerosis	9.44e-05	0.000218	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-DRB1—multiple sclerosis	9.43e-05	0.000218	CbGpPWpGaD
Lithium—GSK3A—Immune System—IFNG—multiple sclerosis	9.32e-05	0.000215	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TGFB1—multiple sclerosis	9.28e-05	0.000214	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCR5—multiple sclerosis	9.27e-05	0.000214	CbGpPWpGaD
Lithium—GSK3A—Disease—TYK2—multiple sclerosis	9.19e-05	0.000212	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL2RA—multiple sclerosis	9.13e-05	0.000211	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MAPK1—multiple sclerosis	9.1e-05	0.00021	CbGpPWpGaD
Lithium—GSK3B—Immune System—ICAM1—multiple sclerosis	9.05e-05	0.000209	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD4—multiple sclerosis	9e-05	0.000208	CbGpPWpGaD
Lithium—GSK3B—Disease—APOE—multiple sclerosis	8.9e-05	0.000206	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL10—multiple sclerosis	8.83e-05	0.000204	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD80—multiple sclerosis	8.71e-05	0.000201	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—multiple sclerosis	8.67e-05	0.0002	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOE—multiple sclerosis	8.43e-05	0.000195	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—multiple sclerosis	8.36e-05	0.000193	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—multiple sclerosis	8.31e-05	0.000192	CbGpPWpGaD
Lithium—GSK3A—Disease—CD4—multiple sclerosis	8.31e-05	0.000192	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL2—multiple sclerosis	8.28e-05	0.000191	CbGpPWpGaD
Lithium—GSK3B—Disease—CD80—multiple sclerosis	8.04e-05	0.000186	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAPK1—multiple sclerosis	8.04e-05	0.000186	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CD86—multiple sclerosis	7.72e-05	0.000178	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CD80—multiple sclerosis	7.62e-05	0.000176	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL5—multiple sclerosis	7.6e-05	0.000176	CbGpPWpGaD
Lithium—GSK3B—Immune System—TYK2—multiple sclerosis	7.35e-05	0.00017	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—POMC—multiple sclerosis	7.24e-05	0.000167	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL2—multiple sclerosis	7.09e-05	0.000164	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SPP1—multiple sclerosis	7.04e-05	0.000163	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—multiple sclerosis	6.99e-05	0.000162	CbGpPWpGaD
Lithium—GSK3A—Immune System—STAT3—multiple sclerosis	6.97e-05	0.000161	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNG—multiple sclerosis	6.89e-05	0.000159	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCR5—multiple sclerosis	6.85e-05	0.000158	CbGpPWpGaD
Lithium—GSK3B—Disease—TYK2—multiple sclerosis	6.79e-05	0.000157	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL2RA—multiple sclerosis	6.75e-05	0.000156	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD4—multiple sclerosis	6.65e-05	0.000154	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TYK2—multiple sclerosis	6.43e-05	0.000149	CbGpPWpGaD
Lithium—GSK3A—Disease—STAT3—multiple sclerosis	6.43e-05	0.000149	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAPK1—multiple sclerosis	6.33e-05	0.000146	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOE—multiple sclerosis	6.23e-05	0.000144	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—multiple sclerosis	6.18e-05	0.000143	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—multiple sclerosis	6.14e-05	0.000142	CbGpPWpGaD
Lithium—GSK3B—Disease—CD4—multiple sclerosis	6.14e-05	0.000142	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL2—multiple sclerosis	6.12e-05	0.000141	CbGpPWpGaD
Lithium—GSK3A—Disease—MYC—multiple sclerosis	5.98e-05	0.000138	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFB1—multiple sclerosis	5.96e-05	0.000138	CbGpPWpGaD
Lithium—GSK3A—Disease—MAPK1—multiple sclerosis	5.85e-05	0.000135	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CD80—multiple sclerosis	5.63e-05	0.00013	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL2—multiple sclerosis	5.35e-05	0.000124	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—POMC—multiple sclerosis	5.35e-05	0.000124	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL2—multiple sclerosis	5.24e-05	0.000121	CbGpPWpGaD
Lithium—GSK3B—Immune System—STAT3—multiple sclerosis	5.15e-05	0.000119	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MMP9—multiple sclerosis	5.07e-05	0.000117	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—multiple sclerosis	4.87e-05	0.000113	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TYK2—multiple sclerosis	4.75e-05	0.00011	CbGpPWpGaD
Lithium—GSK3B—Disease—STAT3—multiple sclerosis	4.75e-05	0.00011	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK1—multiple sclerosis	4.68e-05	0.000108	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—STAT3—multiple sclerosis	4.51e-05	0.000104	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—multiple sclerosis	4.49e-05	0.000104	CbGpPWpGaD
Lithium—GSK3B—Disease—MYC—multiple sclerosis	4.42e-05	0.000102	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFB1—multiple sclerosis	4.41e-05	0.000102	CbGpPWpGaD
Lithium—GSK3B—Disease—MAPK1—multiple sclerosis	4.32e-05	9.99e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MYC—multiple sclerosis	4.19e-05	9.68e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFB1—multiple sclerosis	4.18e-05	9.65e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK1—multiple sclerosis	4.1e-05	9.47e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL2—multiple sclerosis	3.96e-05	9.14e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MMP9—multiple sclerosis	3.74e-05	8.65e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—multiple sclerosis	3.6e-05	8.31e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—STAT3—multiple sclerosis	3.33e-05	7.69e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—multiple sclerosis	3.32e-05	7.68e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—multiple sclerosis	3.15e-05	7.27e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MYC—multiple sclerosis	3.09e-05	7.15e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFB1—multiple sclerosis	3.09e-05	7.13e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK1—multiple sclerosis	3.03e-05	6.99e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—multiple sclerosis	2.33e-05	5.37e-05	CbGpPWpGaD
